about
Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5Pimavanserin for the treatment of Parkinson's disease psychosis.Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant--Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigationβ2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro.Potential serotonergic agents for the treatment of schizophrenia.Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions.Classical and novel pharmacological insights offered by the simple chick cardiomyocyte cell culture model: a valuable teaching aid and a primer for "real" research.Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model.Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.Na+-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1.β-adrenergic Receptor Blocker ICI 118,551 Selectively Increases Intermediate-Conductance Calcium-Activated Potassium Channel (IKCa )-Mediated Relaxations in Rat Main Mesenteric Artery.Serotonin Syndrome Presenting with Concomitant Tramadol and Diphenhydramine Use: A Case Report of an Unlikely Side-Effect.Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
P2860
Q28257584-2A4F93A1-5C9E-4DFA-817C-C6CEAE21D372Q34369646-B2A411DF-BBBD-4ADB-99BE-38C1CED9FAACQ35863912-FD088343-0FBF-4817-BA28-DF75DF65DE65Q36401484-DE9C26F6-082D-4FE2-959D-97BB9D3CA415Q37554447-DF2B9A92-E7EA-412A-9828-86047E4A17F9Q38635792-40C6015F-1805-4E2C-B1B0-75D01B3511BAQ38705545-6F92DB24-4D36-4D3F-9023-D01BC06C8110Q38943231-4DCFD8C4-8BCA-40F0-9567-41C7F73758D6Q46309853-3B49C629-A13D-4BC3-8AAD-72AE1E058BFEQ46792828-38D76797-51CB-4044-8DF5-0F69B5E00CE5Q47194753-89B12B5C-545A-4624-A1F0-DCFCE7DB9167Q47248381-0CA86602-B867-4327-B121-4B3CDB99B836Q55011069-62709A4E-5D9C-41F3-908E-73F68C7E7711Q58798205-6C7D82AE-701E-43A6-B3F5-039B85669139
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inverse agonism and its therapeutic significance.
@ast
Inverse agonism and its therapeutic significance.
@en
Inverse agonism and its therapeutic significance.
@nl
type
label
Inverse agonism and its therapeutic significance.
@ast
Inverse agonism and its therapeutic significance.
@en
Inverse agonism and its therapeutic significance.
@nl
prefLabel
Inverse agonism and its therapeutic significance.
@ast
Inverse agonism and its therapeutic significance.
@en
Inverse agonism and its therapeutic significance.
@nl
P2860
P356
P1476
Inverse agonism and its therapeutic significance.
@en
P2093
Ajeet Kumar Khilnani
Gurudas Khilnani
P2860
P304
P356
10.4103/0253-7613.84947
P407
P577
2011-09-01T00:00:00Z